Home

Using Cryo-EM and collaboration to understand SARS-COV-2 antibodies

Scientists from QCRG and A*STAR reported new findings about COVID-19 neutralizing antibodies, which have important implications for their use as COVID-19 therapies.

Latest QBI News on COVID-19

On June 7, 2021: Scientists at QBI UCSF and University College London published a new study on the B.1.1.7 U.K. coronavirus strain

Creating Collaboration by Breaking Down Scientific Barriers

Cell on March 24, 2021: QBI Director Nevan Krogan and QBI COO Jacqueline Fabius describe QBI's approach to breaking down silos, fostering global collaborations, and sharing the lessons we have learned.